Latest Posts

Company Profile

Coronis NeuroSciences  is a specialty pharma company focused on the development of Innovative therapies in the fields of Neurocognitive and Neurodegenerative disorders. The company owns a pipeline of several clinical and pre-clinical stage molecules and strives to build  value through the clinical development of cutting-edge propriety formulated drugs.

 

Read More

Pipeline

CP201 for ADNP syndrome A trans-nasally delivered peptide (NAP) developed for
the treatment of ADNP syndrome in children
Read More
CP102 for CIAS A novel peptide developed for the treatment of Cognitive Impairment Associated with Schizophrenia
Read More